The clinical significance of Ki-67 as a marker of prognostic value and chemosensitivity prediction in hormone-receptor-positive breast cancer: a meta-analysis of the published literature

Author： Liu Yu   Yin Wenjin   Yan Tingting   Du Yueyao   Shao Zhimin   Lu Jinsong  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.29, Iss.11, 2013-11, pp. : 1453-1461

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Quality-adjusted survival analysis of first-line treatment of hormone-receptor-positive HER2++ metastatic breast cancer with letrozole alone or in combination with lapatinib

By Sherrill Beth   Sherif Bintu   Amonkar Mayur M.   Maltzman Julie   O’Rourke Lisa   Johnston Stephen  

Current Medical Research and Opinion, Vol. 27, Iss. 12, 2011-12 ,pp. : 2245-2252

Informa Healthcare

Access to resources Recommend Favorite

Prognostic Value of Estrogen Receptor and Ki-67 Index after Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer Expressing High Levels of Proliferation at Diagnosis

By  

Oncology, Vol. 79, Iss. 3-4, 2011-03 ,pp. : 255-261

Karger

Access to resources Recommend Favorite

Clinical Utility of Neoadjuvant Endocrine Therapy for Hormone Receptor Positive Breast Cancer

By  

Reviews on Recent Clinical Trials, Vol. 12, Iss. 2, 2017-05 ,pp. : 67-72

Bentham Science Publishers

Access to resources Recommend Favorite

Hormonal Receptor, Human Epidermal Growth Factor Receptor-2, and Ki67 Discordance between Primary Breast Cancer and Paired Metastases: Clinical Impact

By  

Oncology, Vol. 84, Iss. 3, 2012-12 ,pp. : 150-157

Karger

Access to resources Recommend Favorite

Phosphohistone H3 outperforms Ki67 as a marker of outcome for breast cancer patients

By  

HISTOPATHOLOGY, Vol. 309-0167, Iss. 4, 2015-10 ,pp. : 538-547

John Wiley & Sons Inc

Access to resources Recommend Favorite